Discovery Labs adds pharma industry veteran as COO to oversee ambitious growth plans
The Discovery Labs has hired former Baxter Healthcare executive Joerg Ahlgrimm to serve as its president and chief operating officer. He will lead the efforts to bring more than 1,700 people — from manufacturing specialists to doctorate-level scientists — to the site.
Based in King of Prussia, at a campus previously occupied by GlaxoSmithKline, Discovery Labs is a holding company that is specializing in cell and gene therapy development and manufacturing services, large-scale testing, and real estate services for the life sciences industry.
Ahlgrimm told the Philadelphia Business Journal what attracted him to the job was the work Discovery Labs plans to do in cell and gene therapy.
“Cell and gene therapy has the potential to cure people,” he said. “Most therapies today are for treating people. … I have a passion for doing good for humanity, and think cell and gene therapy is going to be the next revolution. I’m hopeful we can help bring those cures to the market.”
The Discovery Labs Appoints President and COO
The Discovery Labs has appointed Joerg Ahlgrimm to the senior leadership position of president and chief operating officer.
Ahlgrimm will be responsible for the day-to-day operations of The Discovery Labs. Central to his responsibilities will be oversight of all operations for the Center for Breakthrough Medicines (CBM) and Testing Centers of America (TCA) – two core Discovery Labs platform companies. This mission includes staffing more than 1,700 people for CBM and TCA – ranging from manufacturing specialists to PhD scientists…